Close Menu

MIT

The Food Allergy Science Initiative seeks to supply the basic scientific research needed to spur future development of diagnostics and therapeutics.

Discovered and characterized through a collaboration between Feng Zhang's lab and the NCBI, C2c2 opens up the RNA world to editing and other applications.

Its first client, Haystack Bio, will use Genecloud to analyze and store single-cell genomics data for a proprietary platform it is developing for the immunotherapy market.

Researchers led by MIT's Jim Collins have built upon their paper-based Ebola test and are hoping to find a partner to help scale production and manufacturing of the test.

Tech-Transfer Maven

Lita Nelsen from the Massachusetts Institute of Technology's technology-transfer office is retiring after decades there.

Fight, Fight, Fight!

The USPTO has become involved in the CRISPR-Cas9 patent dispute.

The patent office has named the Broad Institute, et al. as the junior party in the proceedings and the University of California, et al. as the senior party.

By coupling a microfluidic platform and RNA sequencing, researchers found that single cells belonging to the same lineage have similar transcriptomic profiles.

Feng Zhang has shown how to systematically find and improve CRISPR systems, but scientists haven't settled on how to evaluate them for clinical use.

Scientists from the Zhang laboratory have systematically interrogated the protein structure of Cas9 to optimize its genome editing specificity.

Pages

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.